Quick answers
- What is Sensorcaine Mpf?
- Sensorcaine Mpf is a brand name of Bupivacaine hydrochloride and Bupivacaine hydrochloride and epinephrine bitartrate, a prescription medicine. The FDA NDC Directory lists 7 Sensorcaine Mpf products in 7 strengths and forms.
- Who makes Sensorcaine Mpf?
- Fresenius Kabi USA holds the FDA application for Sensorcaine Mpf (NDA018304, approved December 30, 1981). 1 other company (repackagers or distributors) also list Sensorcaine Mpf products.
- Is there a generic or store brand of Sensorcaine Mpf?
- Yes. The FDA NDC Directory lists 134 other products with the same active ingredients, strength and form as a Sensorcaine Mpf product, 119 of them generic. Ask your pharmacist whether one is right for you.
- Has Sensorcaine Mpf been recalled?
- FDA enforcement reports list 5 recalls of Sensorcaine Mpf products; the newest started November 22, 2022. A recall usually concerns specific lots, not every product.
What Sensorcaine Mpf is
Each Sensorcaine Mpf product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Bupivacaine hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| bupivacaine hydrochloride 2.5 mg/mL injection, solution (epidural, infiltration, intracaudal, perineural) | Sensorcaine Mpf | 38 products, 20 companies | DailyMed |
| bupivacaine hydrochloride 5 mg/mL injection, solution (epidural, infiltration, intracaudal, perineural) | Sensorcaine Mpf | 38 products, 20 companies | DailyMed |
| bupivacaine hydrochloride 5 mg/mL injection, solution (epidural, intracaudal, perineural) | Sensorcaine MPF | 38 products, 20 companies | DailyMed |
| bupivacaine hydrochloride 7.5 mg/mL injection, solution (epidural, retrobulbar) | Sensorcaine Mpf | 15 products, 8 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bupivacaine hydrochloride →
Bupivacaine hydrochloride and epinephrine bitartrate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| bupivacaine hydrochloride 2.5 mg/mL · epinephrine bitartrate 0.005 mg/mL injection, solution (epidural, infiltration, intracaudal, perineural) | Sensorcaine Mpf | 2 products, 2 companies | DailyMed |
| bupivacaine hydrochloride 5 mg/mL · epinephrine bitartrate 0.005 mg/mL injection, solution (epidural, intracaudal, perineural) | Sensorcaine Mpf | 3 products, 3 companies | DailyMed |
| bupivacaine hydrochloride 7.5 mg/mL · epinephrine bitartrate 0.005 mg/mL injection, solution (epidural, retrobulbar) | Sensorcaine Mpf | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bupivacaine hydrochloride and epinephrine bitartrate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA018304 | Fresenius Kabi USA | December 30, 1981 | 3 |
| ANDA070552 | Fresenius Kabi USA | May 21, 1986 | 1 |
| ANDA070553 | Fresenius Kabi USA | May 21, 1986 | 1 |
| ANDA070554 | Fresenius Kabi USA | May 21, 1986 | 1 |
| ANDA070966 | Fresenius Kabi USA | October 13, 1987 | 1 |
Companies that list Sensorcaine Mpf
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Sensorcaine Mpf products.
- Fresenius Kabi USA, LLC6 products
- Henry Schein, Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
November 22, 2022 · Class II · Terminated · D-0127-2023
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 125 mg per 50 mL (2.5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-461-01), packaged in 25 Multiple Dose — Fresenius Kabi USA, LLC
-
November 22, 2022 · Class II · Terminated · D-0129-2023
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 25 mg per 10 mL (2.5 mg per mL), 10 mL Single Dose Vial (NDC 63323-468-01), packaged in 25 Single Dose V — Fresenius Kabi USA, LLC
-
November 22, 2022 · Class II · Terminated · D-0128-2023
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, 250 mg per 50 mL (5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-463-01), packaged in 25 Multiple Dose Via — Fresenius Kabi USA, LLC
-
December 10, 2020 · Class II · Terminated · D-0172-2021
Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fr — Fresenius Kabi USA, LLC
-
April 25, 2016 · Class II · Terminated · D-1037-2016
Presence of Particulate Matter: Glass particulate found in sterile injectable product
Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37 — Fresenius Kabi USA, LLC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.